MaxCyte Sees Prelim. Q3 Total Revenue 7.8M-$8M, Down 27% YoY; Says Decline Is Due To Continued Reduced Customer Activity In The Sector
Portfolio Pulse from Bill Haddad
MaxCyte's preliminary Q3 total revenue is expected to be between $7.8M and $8M, marking a 27% YoY decrease. The company attributes this decline to continued reduced customer activity in the sector.
October 04, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MaxCyte's Q3 revenue is expected to decrease by 27% YoY due to reduced customer activity. This could negatively impact the company's stock price in the short term.
MaxCyte's revenue is a key indicator of its financial health. The expected 27% YoY decrease in Q3 revenue, attributed to reduced customer activity, could negatively impact investor sentiment and lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100